ReviewFrontiers in endocrinology2026

Will GLP-1-based therapies reshape the epidemiology of MASLD? An emerging public health perspective.

Evelyn Nunes Goulart da Silva Pereira et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.